Severity of respiratory syncytial virus compared with SARS-CoV-2 and influenza among hospitalised adults ≥65 years

Our aim was to estimate the risk of pneumonia, admission to intensive care unit (ICU) or death in individuals ≥65 years old admitted to hospital with RSV, compared to influenza or COVID-19. We included hospitalised patients from Severe Acute Respiratory Infection Surveillance in Spain between 2021-2...

ver descrição completa

Detalhes bibliográficos
Autores: Vega-Piris, Lorena., Galindo Carretero, Silvia, Mayordomo, José Luis, Rumayor Zarzuelo, Mercedes Belén, Álvarez Río, Virginia, Gallardo García, Virtudes, García vázquez, Miriam, García Rodríguez, María del Carmen, Basile, Luca, López González-Coviella, Nieves, Barranco Boada, María Isabel, Pérez-Martínez, Olaia, Lameiras Azevedo, Ana, Quiñones Rubio, Carmen, Gimenez Duran, Jaume, Fernández Ibáñez, Ana, García Rivera, María Victoria, Ramos Marín, Violeta, Castrillejo, Daniel, Viloria Raymundo, Luis Javier, Larrauri, Amparo, Monge, Susana
Formato: artículo
Fecha de publicación:2024
País:España
Recursos:Conselleria de Salut i Consum del Govern de les Illes Balears
Repositorio:Docusalut
Idioma:inglés
OAI Identifier:oai:docusalut.com:20.500.13003/21142
Acesso em linha:https://hdl.handle.net/20.500.13003/21142
Access Level:acceso abierto
Palavra-chave:Aged, 80 and over
Aged
SARS-CoV-2
Spain
Hospital Mortality
Humans
Hospitalization
Intensive Care Units
Male
Severity of Illness Index
Influenza, Human
Female
COVID-19
Respiratory Syncytial Virus, Human
Respiratory Syncytial Virus Infections
Infecciones por Virus Sincitial Respiratorio
Femenino
Hospitalización
Gripe Humana
Unidades de Cuidados Intensivos
Masculino
Humanos
Anciano
Mortalidad Hospitalaria
Índice de Severidad de la Enfermedad
Anciano de 80 o más Años
Virus Sincitial Respiratorio Humano
España
id ES_23e4d7b6c1e07e4aed22ebdb45fe069b
oai_identifier_str oai:docusalut.com:20.500.13003/21142
network_acronym_str ES
network_name_str España
repository_id_str
spelling Severity of respiratory syncytial virus compared with SARS-CoV-2 and influenza among hospitalised adults ≥65 yearsVega-Piris, Lorena.Galindo Carretero, SilviaMayordomo, José LuisRumayor Zarzuelo, Mercedes BelénÁlvarez Río, VirginiaGallardo García, VirtudesGarcía vázquez, MiriamGarcía Rodríguez, María del CarmenBasile, LucaLópez González-Coviella, NievesBarranco Boada, María IsabelPérez-Martínez, OlaiaLameiras Azevedo, AnaQuiñones Rubio, CarmenGimenez Duran, JaumeFernández Ibáñez, AnaGarcía Rivera, María VictoriaRamos Marín, VioletaCastrillejo, DanielViloria Raymundo, Luis JavierLarrauri, AmparoMonge, SusanaAged, 80 and overAgedSARS-CoV-2SpainHospital MortalityHumansHospitalizationIntensive Care UnitsMaleSeverity of Illness IndexInfluenza, HumanFemaleCOVID-19Respiratory Syncytial Virus, HumanRespiratory Syncytial Virus InfectionsAged, 80 and overInfecciones por Virus Sincitial RespiratorioFemeninoCOVID-19HospitalizaciónGripe HumanaUnidades de Cuidados IntensivosMasculinoSARS-CoV-2HumanosAncianoMortalidad HospitalariaÍndice de Severidad de la EnfermedadAnciano de 80 o más AñosVirus Sincitial Respiratorio HumanoEspañaOur aim was to estimate the risk of pneumonia, admission to intensive care unit (ICU) or death in individuals ≥65 years old admitted to hospital with RSV, compared to influenza or COVID-19. We included hospitalised patients from Severe Acute Respiratory Infection Surveillance in Spain between 2021-2024, aged ≥65 years, laboratory confirmed for RSV, influenza or SARS-CoV-2. Using a binomial regression with logarithmic link, we estimated the relative risk (RR) of pneumonia, ICU admission and in-hospital mortality, in patients with RSV compared to influenza or SARS-CoV-2, adjusting for age, sex, season and comorbidities. We stratified the estimates by vaccination status for influenza or SARS-CoV2. Among patients unvaccinated for influenza or SARS-CoV-2, those with RSV had similar or lower risk of pneumonia [vs. influenza: RR= 0.91 (95% Confidence Interval: 0.72-1.16); vs. SARS-CoV-2: 0.81 (0.67-0.98)], ICU admission [vs. influenza: 0.93 (0.41-2.08); vs. SARS-CoV-2: 1.10 (0.61-1.99)] and mortality [vs. influenza: 0.64 (0.32-1.28); vs. SARS-CoV-2: 0.56 (0.30-1.04)]. Among the vaccinated, results were largely similar except for a higher risk of ICU admission with RSV [vs. influenza: 2.13(1.16-3.89); vs. SARS-CoV-2: 1.83 (1.02-3.28)] CONCLUSIONS: RSV presented similar or lower intrinsic severity than influenza or SARS-CoV2. Among vaccinated patients, RSV was associated to higher ICU-admission, suggesting the potential for preventive RSV vaccination.Elsevier20242024-11-0120242024-11-01research articlehttp://purl.org/coar/resource_type/c_2df8fbb1info:eu-repo/semantics/articleapplication/pdfhttps://hdl.handle.net/20.500.13003/21142reponame:Docusalutinstname:Conselleria de Salut i Consum del Govern de les Illes BalearsInglésengopen accesshttp://purl.org/coar/access_right/c_abf2Attribution-NonCommercial-NoDerivatives 4.0 Internacionalhttp://creativecommons.org/licenses/by-nc-nd/4.0/info:eu-repo/semantics/openAccessoai:docusalut.com:20.500.13003/211422026-06-22T12:44:07Z
dc.title.none.fl_str_mv Severity of respiratory syncytial virus compared with SARS-CoV-2 and influenza among hospitalised adults ≥65 years
title Severity of respiratory syncytial virus compared with SARS-CoV-2 and influenza among hospitalised adults ≥65 years
spellingShingle Severity of respiratory syncytial virus compared with SARS-CoV-2 and influenza among hospitalised adults ≥65 years
Vega-Piris, Lorena.
Aged, 80 and over
Aged
SARS-CoV-2
Spain
Hospital Mortality
Humans
Hospitalization
Intensive Care Units
Male
Severity of Illness Index
Influenza, Human
Female
COVID-19
Respiratory Syncytial Virus, Human
Respiratory Syncytial Virus Infections
Aged, 80 and over
Infecciones por Virus Sincitial Respiratorio
Femenino
COVID-19
Hospitalización
Gripe Humana
Unidades de Cuidados Intensivos
Masculino
SARS-CoV-2
Humanos
Anciano
Mortalidad Hospitalaria
Índice de Severidad de la Enfermedad
Anciano de 80 o más Años
Virus Sincitial Respiratorio Humano
España
title_short Severity of respiratory syncytial virus compared with SARS-CoV-2 and influenza among hospitalised adults ≥65 years
title_full Severity of respiratory syncytial virus compared with SARS-CoV-2 and influenza among hospitalised adults ≥65 years
title_fullStr Severity of respiratory syncytial virus compared with SARS-CoV-2 and influenza among hospitalised adults ≥65 years
title_full_unstemmed Severity of respiratory syncytial virus compared with SARS-CoV-2 and influenza among hospitalised adults ≥65 years
title_sort Severity of respiratory syncytial virus compared with SARS-CoV-2 and influenza among hospitalised adults ≥65 years
dc.creator.none.fl_str_mv Vega-Piris, Lorena.
Galindo Carretero, Silvia
Mayordomo, José Luis
Rumayor Zarzuelo, Mercedes Belén
Álvarez Río, Virginia
Gallardo García, Virtudes
García vázquez, Miriam
García Rodríguez, María del Carmen
Basile, Luca
López González-Coviella, Nieves
Barranco Boada, María Isabel
Pérez-Martínez, Olaia
Lameiras Azevedo, Ana
Quiñones Rubio, Carmen
Gimenez Duran, Jaume
Fernández Ibáñez, Ana
García Rivera, María Victoria
Ramos Marín, Violeta
Castrillejo, Daniel
Viloria Raymundo, Luis Javier
Larrauri, Amparo
Monge, Susana
author Vega-Piris, Lorena.
author_facet Vega-Piris, Lorena.
Galindo Carretero, Silvia
Mayordomo, José Luis
Rumayor Zarzuelo, Mercedes Belén
Álvarez Río, Virginia
Gallardo García, Virtudes
García vázquez, Miriam
García Rodríguez, María del Carmen
Basile, Luca
López González-Coviella, Nieves
Barranco Boada, María Isabel
Pérez-Martínez, Olaia
Lameiras Azevedo, Ana
Quiñones Rubio, Carmen
Gimenez Duran, Jaume
Fernández Ibáñez, Ana
García Rivera, María Victoria
Ramos Marín, Violeta
Castrillejo, Daniel
Viloria Raymundo, Luis Javier
Larrauri, Amparo
Monge, Susana
author_role author
author2 Galindo Carretero, Silvia
Mayordomo, José Luis
Rumayor Zarzuelo, Mercedes Belén
Álvarez Río, Virginia
Gallardo García, Virtudes
García vázquez, Miriam
García Rodríguez, María del Carmen
Basile, Luca
López González-Coviella, Nieves
Barranco Boada, María Isabel
Pérez-Martínez, Olaia
Lameiras Azevedo, Ana
Quiñones Rubio, Carmen
Gimenez Duran, Jaume
Fernández Ibáñez, Ana
García Rivera, María Victoria
Ramos Marín, Violeta
Castrillejo, Daniel
Viloria Raymundo, Luis Javier
Larrauri, Amparo
Monge, Susana
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv
dc.subject.none.fl_str_mv Aged, 80 and over
Aged
SARS-CoV-2
Spain
Hospital Mortality
Humans
Hospitalization
Intensive Care Units
Male
Severity of Illness Index
Influenza, Human
Female
COVID-19
Respiratory Syncytial Virus, Human
Respiratory Syncytial Virus Infections
Aged, 80 and over
Infecciones por Virus Sincitial Respiratorio
Femenino
COVID-19
Hospitalización
Gripe Humana
Unidades de Cuidados Intensivos
Masculino
SARS-CoV-2
Humanos
Anciano
Mortalidad Hospitalaria
Índice de Severidad de la Enfermedad
Anciano de 80 o más Años
Virus Sincitial Respiratorio Humano
España
topic Aged, 80 and over
Aged
SARS-CoV-2
Spain
Hospital Mortality
Humans
Hospitalization
Intensive Care Units
Male
Severity of Illness Index
Influenza, Human
Female
COVID-19
Respiratory Syncytial Virus, Human
Respiratory Syncytial Virus Infections
Aged, 80 and over
Infecciones por Virus Sincitial Respiratorio
Femenino
COVID-19
Hospitalización
Gripe Humana
Unidades de Cuidados Intensivos
Masculino
SARS-CoV-2
Humanos
Anciano
Mortalidad Hospitalaria
Índice de Severidad de la Enfermedad
Anciano de 80 o más Años
Virus Sincitial Respiratorio Humano
España
description Our aim was to estimate the risk of pneumonia, admission to intensive care unit (ICU) or death in individuals ≥65 years old admitted to hospital with RSV, compared to influenza or COVID-19. We included hospitalised patients from Severe Acute Respiratory Infection Surveillance in Spain between 2021-2024, aged ≥65 years, laboratory confirmed for RSV, influenza or SARS-CoV-2. Using a binomial regression with logarithmic link, we estimated the relative risk (RR) of pneumonia, ICU admission and in-hospital mortality, in patients with RSV compared to influenza or SARS-CoV-2, adjusting for age, sex, season and comorbidities. We stratified the estimates by vaccination status for influenza or SARS-CoV2. Among patients unvaccinated for influenza or SARS-CoV-2, those with RSV had similar or lower risk of pneumonia [vs. influenza: RR= 0.91 (95% Confidence Interval: 0.72-1.16); vs. SARS-CoV-2: 0.81 (0.67-0.98)], ICU admission [vs. influenza: 0.93 (0.41-2.08); vs. SARS-CoV-2: 1.10 (0.61-1.99)] and mortality [vs. influenza: 0.64 (0.32-1.28); vs. SARS-CoV-2: 0.56 (0.30-1.04)]. Among the vaccinated, results were largely similar except for a higher risk of ICU admission with RSV [vs. influenza: 2.13(1.16-3.89); vs. SARS-CoV-2: 1.83 (1.02-3.28)] CONCLUSIONS: RSV presented similar or lower intrinsic severity than influenza or SARS-CoV2. Among vaccinated patients, RSV was associated to higher ICU-admission, suggesting the potential for preventive RSV vaccination.
publishDate 2024
dc.date.none.fl_str_mv 2024
2024-11-01
2024
2024-11-01
dc.type.none.fl_str_mv research article
http://purl.org/coar/resource_type/c_2df8fbb1
dc.type.openaire.fl_str_mv info:eu-repo/semantics/article
format article
dc.identifier.none.fl_str_mv https://hdl.handle.net/20.500.13003/21142
url https://hdl.handle.net/20.500.13003/21142
dc.language.none.fl_str_mv Inglés
eng
language_invalid_str_mv Inglés
language eng
dc.rights.none.fl_str_mv open access
http://purl.org/coar/access_right/c_abf2
Attribution-NonCommercial-NoDerivatives 4.0 Internacional
http://creativecommons.org/licenses/by-nc-nd/4.0/
dc.rights.openaire.fl_str_mv info:eu-repo/semantics/openAccess
rights_invalid_str_mv open access
http://purl.org/coar/access_right/c_abf2
Attribution-NonCommercial-NoDerivatives 4.0 Internacional
http://creativecommons.org/licenses/by-nc-nd/4.0/
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Elsevier
publisher.none.fl_str_mv Elsevier
dc.source.none.fl_str_mv reponame:Docusalut
instname:Conselleria de Salut i Consum del Govern de les Illes Balears
instname_str Conselleria de Salut i Consum del Govern de les Illes Balears
reponame_str Docusalut
collection Docusalut
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869404667909242880
score 15,811543